Full Text View
Tabular View
No Study Results Posted
Related Studies
Pimecrolimus and Epidermal Barrier Function
This study has been completed.
Study NCT01132079   Information provided by University of Kiel

First Received on May 26, 2010.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atopic Dermatitis
Additional conditions recognized in this trial
Dermatitis
Dermatitis, Atopic
More general conditions related to this trial
Genetic Diseases, Inborn
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Genetic
Interventions listed in this trial
cream treatment
Additional drug interventions recognized in this trial
Betamethasone
Pimecrolimus
Tacrolimus
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Dermatologic Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Kiel
Deutsche Forschungsgemeinschaft, Bonn, Germany
Novartis Pharma GmbH, Nürnberg, Germany


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services